002581 未名医药
2024/03 - 三个月2023/122022/122021/122020/12

盈利能力分析
净资产收益率 ROE (%)-1.346-14.929-0.61511.966-8.800
总资产报酬率 ROA (%)-1.206-12.769-0.52210.373-6.661
投入资产回报率 ROIC (%)-1.322-14.131-0.56811.071-7.056

边际利润分析
销售毛利率 (%)80.13380.59678.65778.68680.376
营业利润率 (%)-33.349-68.2559.43067.811-70.679
息税前利润/营业总收入 (%)-32.366-71.1785.60970.558-68.613
净利润/营业总收入 (%)-32.284-74.952-0.24069.203-71.588

收益指标分析
经营活动净收益/利润总额(%)84.01957.758-1,464.805-75.986128.645
价值变动净收益/利润总额(%)25.106-55.1261,708.919169.396-54.324
营业外收支净额/利润总额(%)-4.1006.352-164.6161.9803.025

偿债能力分析
流动比率 (X)6.7053.7181.4232.1993.704
速动比率 (X)5.5793.0791.2031.9503.361
资产负债率 (%)4.5606.99213.58110.35910.351
带息债务/全部投入资本 (%)0.3420.5667.0916.2205.618
股东权益/带息债务 (%)28,773.69017,332.7481,296.2741,490.2921,643.217
股东权益/负债合计 (%)1,989.9101,265.802611.951837.013837.178
利息保障倍数 (X)97.785-41.7192.74251.213-16.067

营运能力分析
应收账款周转天数 (天)137.126125.947211.052255.369492.859
存货周转天数 (天)461.382356.911340.998283.525455.114